A citation-based method for searching scientific literature

Yinghui Li, Qi-Ling Zhou, Wenjie Sun, Prashant Chandrasekharan, Hui Shan Cheng, Zhe Ying, Manikandan Lakshmanan, Anandhkumar Raju, Daniel G Tenen, Shi-Yuan Cheng, Kai-Hsiang Chuang, Jun Li, Shyam Prabhakar, Mengfeng Li, Vinay Tergaonkar. Nat Cell Biol 2015
Times Cited: 117



Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
Times Cited: 121




List of shared articles



Times cited

Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna,[...]. Proc Natl Acad Sci U S A 2021
0

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.
Yujiro Hayashi, Kazutoshi Fujita, George J Netto, Norio Nonomura. Front Oncol 2021
0

The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma.
Jinyu Yu, Jiayi Yu, Xiaowen Wu, Qian Guo, Ting Yin, Zhiyuan Cheng, Jie Dai, Yan Kong, Jun Guo. Clin Sci (Lond) 2020
3

Telomerase: Key regulator of inflammation and cancer.
Lele Wu, Kerem Fidan, Jae-Young Um, Kwang Seok Ahn. Pharmacol Res 2020
10

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
14

The Solo Play of TERT Promoter Mutations.
François Hafezi, Danielle Perez Bercoff. Cells 2020
8

TERT, a promoter of CNS malignancies.
Bhuvic Patel, Rukayat Taiwo, Albert H Kim, Gavin P Dunn. Neurooncol Adv 2020
7

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.
Paola Del Bianco, Camilla Stagni, Silvia Giunco, Alessio Fabozzi, Lisa Elefanti, Stefania Pellegrini, Antonella Vecchiato, Jacopo Pigozzo, Carolina Zamuner, Anita De Rossi,[...]. Cancers (Basel) 2020
5

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler,[...]. Clin Cancer Res 2020
5

Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.
Maria Giovanna Maturo, Sivaramakrishna Rachakonda, Barbara Heidenreich, Cristina Pellegrini, Nalini Srinivas, Celia Requena, Carlos Serra-Guillen, Beatriz Llombart, Onofre Sanmartin, Carlos Guillen,[...]. Sci Rep 2020
6


Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
10

TERT-Regulation and Roles in Cancer Formation.
Marta Dratwa, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, Katarzyna Bogunia-Kubik. Front Immunol 2020
6

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Juan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, Nalini Srinivas, Alexander Skorokhod, Celia Requena, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. Int J Cancer 2019
21

TERT gene: its function and dysregulation in cancer.
Andrew J Colebatch, Alexander Dobrovic, Wendy A Cooper. J Clin Pathol 2019
18

When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.
Saumya R Bollam, Michael E Berens, Harshil D Dhruv. Curr Neurol Neurosci Rep 2018
3

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Andrew Mancini, Ana Xavier-Magalhães, Wendy S Woods, Kien-Thiet Nguyen, Alexandra M Amen, Josie L Hayes, Christof Fellmann, Michael Gapinske, Andrew M McKinney, Chibo Hong,[...]. Cancer Cell 2018
43

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression.
Jaskaren S Kohli, Hira Mir, Afsheen Wasif, Heung Chong, Victoria Akhras, Rajiv Kumar, Eduardo Nagore, Dorothy C Bennett. Oncotarget 2017
5